Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

NCT03749460 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Neoplasm in the Bone
Metastatic Malignant Neoplasm in the Lung
Salivary Gland Carcinoma
Stage IV Major Salivary Gland Cancer AJCC v8
Stage IVA Major Salivary Gland Cancer AJCC v8
Stage IVB Major Salivary Gland Cancer AJCC v8
Stage IVC Major Salivary Gland Cancer AJCC v8

Interventions

BIOLOGICAL: Nivolumab
BIOLOGICAL: Ipilimumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

University of Washington